Convey Health Solutions Holdings, Inc. CNVY
We take great care to ensure that the data presented and summarized in this overview for Convey Health Solutions Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CNVY
Top Purchases
Top Sells
About CNVY
Convey Health Solutions Holdings, Inc. provides technology enabled solutions and advisory services to assist its clients with workflows across product developments, sales, member experience, clinical management, core operations, and business intelligence and analytics. It operates through two segments, Technology Enabled Solutions and Advisory Services. The Technology Enabled Solutions segment offers technology solutions through web-based customizable application that is used to identify, track, and administer contractual services, or benefits provided under a client's plan to its Medicare and Medicaid beneficiaries. It also provides analytics over healthcare data to capture and assess gaps in risk documentation, quality, clinical care, and compliance. The company also offers health plan management, data analytics, supplemental benefit, advisory, and software services. The Advisory Services segment offers sales and marketing strategies, provider network strategies, compliance, star ratings, quality, clinical, pharmacy, analytics, and risk adjustment. It serves government sponsored, medicare advantage, medicare, as well as pharmacy benefits managers. The company was founded in 2001 and is headquartered in Fort Lauderdale, Florida. Convey Health Solutions Holdings, Inc. is a former subsidiary of TPG Cannes Aggregation, L.P.
Insider Transactions at CNVY
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 07
2022
|
John E. Steele EVP, Technology |
SELL
Sale (or disposition) back to the issuer
|
Direct |
182,395
-96.93%
|
$1,823,950
$10.5 P/Share
|
|
Oct 07
2022
|
William Carl Whitmer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,200
-100.0%
|
$252,000
$10.5 P/Share
|
|
Oct 07
2022
|
Timothy Fairbanks Chief Financial Officer & EVP |
SELL
Sale (or disposition) back to the issuer
|
Direct |
53,287
-96.15%
|
$532,870
$10.5 P/Share
|
|
Oct 07
2022
|
Kyle Stern Mng Partner, HealthScape & EVP |
SELL
Sale (or disposition) back to the issuer
|
Direct |
154,191
-97.08%
|
$1,541,910
$10.5 P/Share
|
|
Oct 07
2022
|
Stephen C Farrell CHIEF EXECUTIVE OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
163,373
-97.18%
|
$1,633,730
$10.5 P/Share
|
|
Sep 15
2022
|
Kyle Stern Mng Partner, HealthScape & EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
818
-0.13%
|
$8,180
$10.5 P/Share
|
|
Sep 15
2022
|
Kyle Stern Mng Partner, HealthScape & EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
2,790
+0.45%
|
-
|
|
Sep 15
2022
|
John E. Steele EVP, Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
818
-0.11%
|
$8,180
$10.5 P/Share
|
|
Sep 15
2022
|
John E. Steele EVP, Technology |
BUY
Exercise of conversion of derivative security
|
Direct |
2,790
+0.37%
|
-
|
|
Sep 07
2022
|
Susana Pichardo SVP, Accounting |
SELL
Open market or private sale
|
Direct |
71,651
-100.0%
|
$716,510
$10.5 P/Share
|
|
Sep 07
2022
|
Susana Pichardo SVP, Accounting |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
71,651
+39.71%
|
$501,557
$7.35 P/Share
|
|
Jun 15
2022
|
Kyle Stern Mng Partner, HealthScape & EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
3,271
-0.53%
|
$9,813
$3.97 P/Share
|
|
Jun 15
2022
|
Kyle Stern Mng Partner, HealthScape & EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
11,161
+1.77%
|
-
|
|
Jun 15
2022
|
John E. Steele EVP, Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
3,271
-0.43%
|
$9,813
$3.97 P/Share
|
|
Jun 15
2022
|
John E. Steele EVP, Technology |
BUY
Exercise of conversion of derivative security
|
Direct |
11,161
+1.45%
|
-
|
|
Jun 18
2021
|
Tpg Group Holdings (Sbs) Advisors, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,666,667
-2.96%
|
$21,666,671
$13.02 P/Share
|
|
Jun 18
2021
|
Stephen C Farrell CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
45,000
+6.6%
|
$585,000
$13.0 P/Share
|
|
Jun 18
2021
|
John E. Steele EVP, Technology |
BUY
Open market or private purchase
|
Direct |
38,500
+4.88%
|
$462,000
$12.94 P/Share
|
|
Jun 18
2021
|
Kyle Stern Mng Partner, HealthScape & EVP |
BUY
Open market or private purchase
|
Direct |
38,760
+5.99%
|
$503,880
$13.12 P/Share
|